BIMI Holdings Inc. (NASDAQ:BIMI – Get Free Report) saw a significant growth in short interest in June. As of June 15th, there was short interest totalling 68,600 shares, a growth of 251.8% from the May 31st total of 19,500 shares. Approximately 3.7% of the company’s stock are short sold. Based on an average daily volume of 101,000 shares, the days-to-cover ratio is currently 0.7 days.
BIMI Price Performance
Shares of NASDAQ BIMI traded up $0.06 during mid-day trading on Thursday, hitting $1.38. The company had a trading volume of 10,464 shares, compared to its average volume of 70,168. BIMI has a 1 year low of $1.01 and a 1 year high of $4.13. The stock’s 50-day moving average price is $1.26 and its 200-day moving average price is $2.03.
Hedge Funds Weigh In On BIMI
A hedge fund recently bought a new stake in BIMI stock. Hudson Bay Capital Management LP purchased a new stake in shares of BIMI Holdings Inc. (NASDAQ:BIMI – Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 200,000 shares of the company’s stock, valued at approximately $295,000. Hudson Bay Capital Management LP owned about 1.73% of BIMI at the end of the most recent reporting period. Hedge funds and other institutional investors own 0.11% of the company’s stock.
BIMI Company Profile
BIMI Holdings Inc, together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies.
Recommended Stories
- Five stocks we like better than BIMI
- The 3 Best Blue-Chip Stocks to Buy Now
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- Are Penny Stocks a Good Fit for Your Portfolio?
- Progress Software Stock Back in the Green After Beating Forecasts
- Buy P&G Now, Before It Sets A New All-Time High
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for BIMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIMI and related companies with MarketBeat.com's FREE daily email newsletter.